Related Experiment Video
Updated: Nov 18, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Nocturnal Systolic Hypertension and Adverse Prognosis in Patients with CKD
Qin Wang1, Yu Wang1, Jinwei Wang1
1Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, National Health and Family Planning Commission of the People's Republic of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing, China.
Insights
Nocturnal systolic hypertension, alone or combined, elevates risks for cardiovascular events and kidney failure in chronic kidney disease (CKD) patients. Isolated nocturnal diastolic hypertension showed no significant association with adverse outcomes.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Research
Background:
- Nocturnal hypertension is linked to poor outcomes in chronic kidney disease (CKD).
- The specific impact of different nocturnal hypertension types on CKD progression and cardiovascular events remains unclear.
Purpose of the Study:
- To investigate the association between distinct entities of nocturnal hypertension and the risks of kidney failure and cardiovascular events in CKD patients.
- To clarify the prognostic value of isolated nocturnal systolic hypertension, isolated nocturnal diastolic hypertension, and combined nocturnal systolic-diastolic hypertension.
Main Methods:
- Analysis of data from the Chinese Cohort Study of Chronic Kidney Disease.
- Categorization of nocturnal hypertension into isolated diastolic, isolated systolic, and systolic-diastolic types.
- Utilized Cox regression to assess associations with kidney failure and cardiovascular outcomes.
Main Results:
- Among 2024 CKD patients, 73% had nocturnal hypertension.
- Isolated nocturnal systolic hypertension (8% of cases) increased cardiovascular event risk (HR, 3.17).
- Nocturnal systolic-diastolic hypertension (66% of cases) elevated risks for both kidney failure (HR, 1.71) and cardiovascular events (HR, 2.19).
- Isolated nocturnal diastolic hypertension showed no significant association with adverse outcomes.
Conclusions:
- Nocturnal systolic hypertension, whether isolated or combined, is a significant risk factor for adverse outcomes in CKD.
- These findings highlight the importance of monitoring systolic blood pressure during nighttime in CKD management.
Background And Objectives:
Nocturnal hypertension is associated with adverse outcomes in patients with CKD. However, the individual association of entities of nocturnal hypertension according to achievement of systolic and/or diastolic BP goals with kidney failure and cardiovascular outcomes of CKD is not clear.
Design, Setting, Participants, & Measurements:
Our study analyzed data from participants in the Chinese Cohort Study of Chronic Kidney Disease. Nocturnal hypertension was categorized into three entities: isolated nocturnal diastolic hypertension with diastolic BP ≥70 mm Hg and systolic BP <120 mm Hg, isolated nocturnal systolic hypertension with systolic BP ≥120 mm Hg and diastolic BP <70 mm Hg, and nocturnal systolic-diastolic hypertension with both systolic BP ≥120 mm Hg and diastolic BP ≥70 mm Hg. Associations of nocturnal hypertension entities with kidney failure and cardiovascular outcomes were evaluated by Cox regression.
Results:
In total, 2024 patients with CKD stages 1-4 were included in our analysis (mean age, 49±14 years; 57% men; eGFR=51±29 ml/min per 1.73 m2; proteinuria: 0.9 [0.4-2.1] g/d). Among them, 1484 (73%) patients had nocturnal hypertension, with the proportions of 26%, 8%, and 66% for isolated nocturnal diastolic hypertension, isolated nocturnal systolic hypertension, and nocturnal systolic-diastolic hypertension, respectively. Three hundred twenty kidney events and 148 cardiovascular events were recorded during median follow-up intervals of 4.8 and 5.0 years for kidney and cardiovascular events, respectively. After adjustment, isolated nocturnal systolic hypertension was associated with a higher risk for cardiovascular events (hazard ratio, 3.17; 95% confidence interval, 1.61 to 6.23). Nocturnal systolic-diastolic hypertension showed a higher risk for both kidney failure (hazard ratio, 1.71; 95% confidence interval, 1.17 to 2.49) and cardiovascular outcomes (hazard ratio, 2.19; 95% confidence interval, 1.24 to 3.86). No association was observed between isolated nocturnal diastolic hypertension with either kidney failure or cardiovascular events.
Conclusions:
Nocturnal systolic hypertension, either alone or in combination with diastolic hypertension, is associated with higher risks for adverse outcomes in patients with CKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies

